Home/Filings/4/A/0001193805-20-000550
4/A//SEC Filing

Guiheen Lawrence P. 4/A

Accession 0001193805-20-000550

CIK 0001368514other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 5:10 PM ET

Size

6.5 KB

Accession

0001193805-20-000550

Insider Transaction Report

Form 4/AAmended
Period: 2020-02-28
Transactions
  • Award

    Common Stock

    2020-02-28+7,50077,500 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,000
Footnotes (3)
  • [F1]These shares represent restricted stock units ("RSUs"). Subsequent to the filing of the initial Form 4 by the Reporting Person on March 3, 2020, the Board of Directors of the Issuer corrected the vesting schedule of the RSUs. The RSUs will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting.
  • [F2]Includes (i) 7,500 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 70,000 shares of common stock owned by the reporting person.
  • [F3]These shares are owned by the Guiheen Trust, of which Mr. Guiheen serves as a joint trustee.

Issuer

ADMA BIOLOGICS, INC.

CIK 0001368514

Entity typeother

Related Parties

1
  • filerCIK 0001554353

Filing Metadata

Form type
4/A
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 5:10 PM ET
Size
6.5 KB